Metabolic effect of sacubitril-valsartan combination: beware of hypoglycemia!

被引：0
|
作者：
Guetlin, M. [1 ]
Joubert, M. [1 ,2 ]
机构：
[1] CHU Caen, Serv Endocrinol Diabetol, Caen, France
[2] Univ Caen Normandie UNICAEN, Caen, France
来源：
CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION | 2024年 / 28卷 / 02期
关键词：
Sacubitril-valsartan; Heart failure with reduced ejection fraction; Diabetes; Hypoglycemia; NEPRILYSIN;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Sacubitril-valsartan combination, a treatment for heart failure with reduced ejection fraction, also presents metabolic effects on glucose, particularly in patients with diabetes: several studies have shown a reduction in glycated hemoglobin (HbA1c), a reduction in insulin requirements, along with an increase of hypoglycemic risk. While the mechanisms of these metabolic effects are not fully understood, they may involve neprilysin inhibition and increased glucagon-like peptide-1 (GLP1) levels.
引用
收藏
页码：78 / 80
页数：3
相关论文
共 50 条
  • [1] Resolution of Hypoglycemia Following Cessation of Sacubitril-Valsartan Combination Therapy in a Nondiabetic Patient
    Morgan, Georgia
    Chowdhury, Sharmistha Roy
    CJC OPEN, 2023, 5 (03) : 396 - 399
  • [2] Sacubitril-valsartan and its effect on echocardiographic parameters
    Mesquita Guimaraes, J.
    Borges Rosa, J.
    Martinho, A.
    Almeida, J.
    Fernandes, D.
    Monteiro, E.
    Costa, G.
    Costa, S.
    Franco, F.
    Baptista, R.
    Castro, G.
    Goncalves, L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 131 - 131
  • [3] Sacubitril-valsartan and its effect on ventricular remodeling
    Abellas Sequeiros, M. Maria
    Del Prado, S.
    Alonso Salinas, G.
    Lorente Ros, A.
    Vieitez Florez, J. M.
    Moya Mur, J. L.
    Garcia Martin, A.
    Jimenez Nacher, J. J.
    Fernandez Golfin, C.
    Zamorano Gomez, J. L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 236 - 236
  • [4] Sacubitril-valsartan: the earlier, the better?
    Ana Filipa Cardoso, A.
    Tinoco, M.
    Dias, G.
    Faria, B.
    Pereira, T.
    Fernandes, M.
    Almeida, F.
    Lourenco, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 125 - 125
  • [5] Sacubitril-Valsartan in Heart Failure
    Vitting, Kevin E.
    ANNALS OF INTERNAL MEDICINE, 2017, 166 (09) : 680 - 680
  • [6] Effect of sacubitril-valsartan on cardiac function in hemodialysis patients
    Daimon, Shoichiro
    Yasuda, Miyuki
    Maeda, Kazumasa
    THERAPEUTIC APHERESIS AND DIALYSIS, 2022, 26 (01) : 244 - 245
  • [7] Mechanisms of sacubitril-valsartan benefit in HFrEF
    Fernandez-Ruiz, Irene
    NATURE REVIEWS CARDIOLOGY, 2019, 16 (11) : 648 - 648
  • [8] Potential Markers of Sacubitril-Valsartan Tolerance
    Ramirez, Gabrielle L.
    Nicklas, Todd
    Fink, Matthew
    Margulies, Kenneth
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S61 - S62
  • [9] Adoption of sacubitril-valsartan in the Medicare population
    Kahn, Peter A.
    Riello, Ralph J.
    Ahmad, Tariq
    Desai, Nihar R.
    AMERICAN HEART JOURNAL, 2020, 223 : 81 - 83
  • [10] Sacubitril-Valsartan in Patients Requiring Hemodialysis
    Le, Dustin
    Grams, Morgan E.
    Coresh, Josef
    Shin, Jung-Im
    JAMA NETWORK OPEN, 2024, 7 (08)
12345